2-29920191-G-A

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_004304.5(ALK):​c.469C>T​(p.Pro157Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000285 in 1,612,784 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P157L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00052 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00026 ( 0 hom. )

Consequence

ALK
NM_004304.5 missense

Scores

3
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:3

Conservation

PhyloP100: 2.37

Publications

4 publications found
Variant links:
Genes affected
ALK (HGNC:427): (ALK receptor tyrosine kinase) This gene encodes a receptor tyrosine kinase, which belongs to the insulin receptor superfamily. This protein comprises an extracellular domain, an hydrophobic stretch corresponding to a single pass transmembrane region, and an intracellular kinase domain. It plays an important role in the development of the brain and exerts its effects on specific neurons in the nervous system. This gene has been found to be rearranged, mutated, or amplified in a series of tumours including anaplastic large cell lymphomas, neuroblastoma, and non-small cell lung cancer. The chromosomal rearrangements are the most common genetic alterations in this gene, which result in creation of multiple fusion genes in tumourigenesis, including ALK (chromosome 2)/EML4 (chromosome 2), ALK/RANBP2 (chromosome 2), ALK/ATIC (chromosome 2), ALK/TFG (chromosome 3), ALK/NPM1 (chromosome 5), ALK/SQSTM1 (chromosome 5), ALK/KIF5B (chromosome 10), ALK/CLTC (chromosome 17), ALK/TPM4 (chromosome 19), and ALK/MSN (chromosome X).[provided by RefSeq, Jan 2011]
ALK Gene-Disease associations (from GenCC):
  • neuroblastoma, susceptibility to, 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009894013).
BP6
Variant 2-29920191-G-A is Benign according to our data. Variant chr2-29920191-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 239842.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000519 (79/152224) while in subpopulation NFE AF = 0.000823 (56/68040). AF 95% confidence interval is 0.000651. There are 1 homozygotes in GnomAd4. There are 35 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 79 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004304.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALK
NM_004304.5
MANE Select
c.469C>Tp.Pro157Ser
missense
Exon 1 of 29NP_004295.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALK
ENST00000389048.8
TSL:1 MANE Select
c.469C>Tp.Pro157Ser
missense
Exon 1 of 29ENSP00000373700.3
ENSG00000233862
ENST00000669284.1
n.157+35058C>T
intron
N/A
ENSG00000233862
ENST00000769926.1
n.534+6028C>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.000519
AC:
79
AN:
152224
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000964
Gnomad AMI
AF:
0.0121
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000823
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000213
AC:
52
AN:
244624
AF XY:
0.000194
show subpopulations
Gnomad AFR exome
AF:
0.0000684
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.000403
Gnomad EAS exome
AF:
0.000111
Gnomad FIN exome
AF:
0.000190
Gnomad NFE exome
AF:
0.000363
Gnomad OTH exome
AF:
0.000168
GnomAD4 exome
AF:
0.000260
AC:
380
AN:
1460560
Hom.:
0
Cov.:
31
AF XY:
0.000311
AC XY:
226
AN XY:
726596
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33476
American (AMR)
AF:
0.00
AC:
0
AN:
44696
Ashkenazi Jewish (ASJ)
AF:
0.000689
AC:
18
AN:
26130
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39688
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86234
European-Finnish (FIN)
AF:
0.000210
AC:
11
AN:
52372
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5764
European-Non Finnish (NFE)
AF:
0.000300
AC:
334
AN:
1111888
Other (OTH)
AF:
0.000199
AC:
12
AN:
60312
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
28
56
83
111
139
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000519
AC:
79
AN:
152224
Hom.:
1
Cov.:
33
AF XY:
0.000471
AC XY:
35
AN XY:
74358
show subpopulations
African (AFR)
AF:
0.0000964
AC:
4
AN:
41476
American (AMR)
AF:
0.0000654
AC:
1
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000823
AC:
56
AN:
68040
Other (OTH)
AF:
0.000478
AC:
1
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00162
Hom.:
0
Bravo
AF:
0.000325
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000117
AC:
1
ExAC
AF:
0.000239
AC:
29
EpiCase
AF:
0.000545
EpiControl
AF:
0.000416

ClinVar

ClinVar submissions as Germline
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
1
Neuroblastoma, susceptibility to, 3 (3)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
2
-
not provided (2)
-
1
-
ALK-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.066
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
12
DANN
Uncertain
0.98
DEOGEN2
Benign
0.11
T
Eigen
Benign
-0.82
Eigen_PC
Benign
-0.74
FATHMM_MKL
Benign
0.30
N
LIST_S2
Benign
0.57
T
M_CAP
Benign
0.084
D
MetaRNN
Benign
0.0099
T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
0.69
N
PhyloP100
2.4
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-0.45
N
REVEL
Benign
0.031
Sift
Uncertain
0.028
D
Sift4G
Uncertain
0.053
T
Polyphen
0.0
B
Vest4
0.15
MVP
0.44
MPC
0.17
ClinPred
0.033
T
GERP RS
-0.74
Varity_R
0.028
gMVP
0.17
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs74774946; hg19: chr2-30143057; API